Argus
•
Mar 26, 2025
COLL: Raising target price to $32.00
Summary
Collegium Pharmaceutical Inc is a specialty pharma
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Pfizer Inc.
Apr 03, 2025
•
PFE
ANIP: Raising target price to $71.00
Apr 02, 2025
•
ANIP
PTGX: Lowering target price to $49.00
Apr 02, 2025
•
PTGX
INVA: Raising target price to $19.00
Apr 02, 2025
•
INVA
AMPH: What does Argus have to say about AMPH?
Apr 02, 2025
•
AMPH